Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.

Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, Beyer-Westendorf J, Bonacchini L, Brachmann J, Christ M, Czihal M, Duerschmied D, Empen K, Espinola-Klein C, Ficker JH, Fonseca C, Genth-Zotz S, Jiménez D, Harjola VP, Held M, Iogna Prat L, Lange TJ, Manolis A, Meyer A, Mustonen P, Rauch-Kroehnert U, Ruiz-Artacho P, Schellong S, Schwaiblmair M, Stahrenberg R, Westerweel PE, Wild PS, Konstantinides SV, Lankeit M, HoT-PE Investigators.

Open source

DOI: 10.1093/eurheartj/ehz367
Published: 2020-01-01
Container: Eur Heart J
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehz367,
  title = {Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.},
  author = {Barco S and  Schmidtmann I and  Ageno W and  Bauersachs RM and  Becattini C and  Bernardi E and  Beyer-Westendorf J and  Bonacchini L and  Brachmann J and  Christ M and  Czihal M and  Duerschmied D and  Empen K and  Espinola-Klein C and  Ficker JH and  Fonseca C and  Genth-Zotz S and  Jiménez D and  Harjola VP and  Held M and  Iogna Prat L and  Lange TJ and  Manolis A and  Meyer A and  Mustonen P and  Rauch-Kroehnert U and  Ruiz-Artacho P and  Schellong S and  Schwaiblmair M and  Stahrenberg R and  Westerweel PE and  Wild PS and  Konstantinides SV and  Lankeit M and  HoT-PE Investigators.},
  year = {2020},
  journal = {Eur Heart J},
  doi = {10.1093/eurheartj/ehz367},
  url = {https://doi.org/10.1093/eurheartj/ehz367}
}

RIS

TY  - JOUR
TI  - Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.
AU  - Barco S
AU  -  Schmidtmann I
AU  -  Ageno W
AU  -  Bauersachs RM
AU  -  Becattini C
AU  -  Bernardi E
AU  -  Beyer-Westendorf J
AU  -  Bonacchini L
AU  -  Brachmann J
AU  -  Christ M
AU  -  Czihal M
AU  -  Duerschmied D
AU  -  Empen K
AU  -  Espinola-Klein C
AU  -  Ficker JH
AU  -  Fonseca C
AU  -  Genth-Zotz S
AU  -  Jiménez D
AU  -  Harjola VP
AU  -  Held M
AU  -  Iogna Prat L
AU  -  Lange TJ
AU  -  Manolis A
AU  -  Meyer A
AU  -  Mustonen P
AU  -  Rauch-Kroehnert U
AU  -  Ruiz-Artacho P
AU  -  Schellong S
AU  -  Schwaiblmair M
AU  -  Stahrenberg R
AU  -  Westerweel PE
AU  -  Wild PS
AU  -  Konstantinides SV
AU  -  Lankeit M
AU  -  HoT-PE Investigators.
PY  - 2020
JO  - Eur Heart J
DO  - 10.1093/eurheartj/ehz367
UR  - https://doi.org/10.1093/eurheartj/ehz367
ER  -

APA

S, B., I, S., W, A., RM, B., C, B., E, B., J, B., L, B., J, B., M, C., M, C., D, D., K, E., C, E., JH, F., C, F., S, G., D, J., VP, H., M, H., L, I. P., TJ, L., A, M., A, M., P, M., U, R., P, R., S, S., M, S., R, S., PE, W., PS, W., SV, K., M, L., & Investigators., H. (2020). Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.. Eur Heart J. https://doi.org/10.1093/eurheartj/ehz367

Source records

europe-pmc · retrieved 2026-09-27T05:54:21.235Z